Ads
related to: sellas life sciences stock forecast model- Capital Ideas Webinars
Our Brightest Minds Answer
Your Questions.
- Subscribe to Newsletter
Receive Our Latest Investment
Thinking In Your Inbox Each Week.
- Guide to Recessions
9 Things You Need to Know to
Prepare for a Recession.
- Fixed Income Insights
View Our Latest Fixed Income
Investment Insights.
- Capital Ideas Webinars
Search results
Results From The WOW.Com Content Network
Merger with Sellas Life Sciences. In 2017, Galena Biopharma Inc. announced a merger "with privately-held oncology company Sellas Life Sciences Group Ltd. in an all-stock transaction." The combined company was Sellas Life Science Group. The newly merged companies focused on the development of novel treatments for cancer.
SELLAS Life Sciences Group ( NASDAQ:SLS ) Third Quarter 2022 Results Key Financial Results Net loss: US$7.02m (flat on... SELLAS Life Sciences Group Third Quarter 2022 Earnings: US$0.34 loss per ...
For premium support please call: 800-290-4726 more ways to reach us
SELLAS Life Sciences Group Inc (NASDAQ: SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian ...
IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles. [30] [31] The merger was completed in October and the resulting company was a $17.6 billion company called QuintilesIMS. [9]
List of largest biomedical companies by market capitalization. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) with current market capitalization of at least US$10 billion, ranked by their market capitalization. It does not include biotechnology companies that ...
Ads
related to: sellas life sciences stock forecast model